Table 1.

Correlation between circZNF566 expression and clinicopathological features in HCC tissues (n = 57, χ²-test).

	N	CicrZNF566	Expression	P-value
		High (%)	Low (%)
Age (year)				0.520
<60	45	24 (53.3%)	21 (46.7%)
≥60	12	8 (66.7%)	4 (33.3%)
Gender				0.092
Male	46	26 (71.7%)	20 (90.9%)
Female	11	6 (55.5%)	5 (45.5%)
Tumor number				0.502
Single	49	27 (55.1%)	22 (44.9%)
Multiple	8	5 (62.5%)	3 (37.5%)
Tumor size				0.035
<5 cm	27	16 (59.3%)	11 (40.7%)
≥5 cm	30	21 (70.0%)	9 (30.0%)
Tumor differentiation				0.011
I–II	37	16 (51.8%)	21 (43.2%)
III–IV	20	16 (80.0%)	4 (20.0%)
Tumor location				0.856
Left liver	10	5 (50.0%)	5 (50.0%)
Right liver	42	25 (59.5%)	17 (40.5%)
Whole liver	5	3 (60.0%)	2 (40.0%)
Vascular invasion				0.085
Yes	16	12 (75.0%)	4 (25.0%)
No	41	21 (51.2%)	20 (48.8%)
Liver cirrhosis				1.000
Yes	29	17 (58.6%)	12 (41.4%)
No	28	16 (57.1%)	12 (42.9%)
Hepatitis virus				0.227
Yes	6	4 (66.7%)	2 (33.3%)
No	51	31 (60.8%)	20 (39.2%)
M stage				0.016
M0	46	24 (52.2%)	22 (47.8%)
M1	11	10 (90.9%)	1 (9.1%)